USA

The decision followed a comprehensive systematic review of published literature, which included case reports containing patient-level data and mechanistic studies that demonstrated the treatment’s potential benefits.

The platform serves multiple surgical disciplines, including arthroscopy, bariatric surgery, general surgery, gynecology, hepatopancreatobiliary transplant procedures, thoracic surgery, and urology.

The platform integrates medical devices and health information systems, creating a connected data thread with central monitoring and surveillance workflows that support clinical decision-making across encounters and over time.

The facilities house 27 specialized production suites capable of manufacturing over 2 billion tablets and capsules annually, providing substantial capacity for both clinical and commercial-scale operations.

CSL plans to incorporate its Horizon 2 production process into the expanded facility, which the company describes as a cornerstone of its global manufacturing growth strategy.

By combining its global operations with Biocare’s established commercial presence across the United States, the company aims to reach a wider customer base and strengthen its market position.

SmartHeart can cut the number of required breath-holds for basic views by up to 75%, making the examination considerably more comfortable for those being scanned.

The self-administered nasal spray therapy bridges the gap between oral and intravenous diuretic treatments, offering patients an outpatient option for managing their condition.

The LEED Gold-certified facility features flexible laboratory configurations and advanced mechanical and utility systems, enabling researchers to conduct intricate scientific research.

Abbott engineered the HERO reader to be 60% lighter than its predecessor, making it practical for daily use and convenient enough for patients to carry during travel.